Preliminary Results on Clinical Effects of Probiotic Lactobacillus salivarius LS01 in Children Affected by Atopic Dermatitis
Authors:
- Anna L. ArtesiAAAnna L. Artesi
- Francesco CandioFCFrancesco Candio
- Sara CeccarelliSCSara Ceccarelli
- Rita CozzaliRCRita Cozzali
- Luigi FerraroLFLuigi Ferraro
- Donatella FiumanaDFDonatella Fiumana
- Manuela MencacciMMManuela Mencacci
- Maurizio MorlupoMMMaurizio Morlupo
- Paola PazzelliPPPaola Pazzelli
- Laura RossiLRLaura Rossi
- Marco ToscanoMTMarco Toscano
- 1 November 2014
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 48 (Supplement) , S34-S36
Abstract
The goal of this study was to evaluate the clinical efficacy of an intake of Lactobacillus salivarius LS01 (DSM 22775) for the treatment of atopic dermatitis (AD) in children. AD is an inflammatory and pruritic chronic relapsing skin disorder with multifactorial etiopathology. Some evidence suggests that probiotics may improve AD by modulating the immune system and the composition of intestinal microbiota. A total of 43 patients aged from 0 to 11 years were enrolled in the study (M/F ratio=1:1) and treated with the probiotic strain L. salivarius LS01. Clinical efficacy of probiotic treatment was assessed from baseline by changes in itch index and in the objective SCORAD/SCORAD index. Patients being given probiotic treatment showed a significant improvement in clinical parameters (SCORAD and itch values) from baseline. The reduction in SCORAD and itch index observed after 4 weeks of treatment also persisted after the cessation of probiotic supplementation. L. salivarius LS01 seems to be able to improve the quality of life of children affected by AD and, as a consequence, it may have promising clinical and research implications.Keywords
This publication has 18 references indexed in Scilit:
- Effects of probiotics on the prevention of atopic dermatitisKorean Journal of Pediatrics, 2012
- Quality of life measures in Italian children with atopic dermatitis and their familiesItalian Journal of Pediatrics, 2011
- Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010PLOS ONE, 2011
- Serological Markers for Inflammatory Bowel Disease in AIDS Patients with Evidence of Microbial TranslocationPLOS ONE, 2010
- Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro modelBMC Research Notes, 2010
- Probiotics for the Treatment or Prevention of Atopic DermatitisAmerican Journal of Clinical Dermatology, 2008
- What are the best outcome measurements for atopic eczema? A systematic reviewJournal of Allergy and Clinical Immunology, 2007
- No effects of probiotics on atopic dermatitis in infancy: a randomized placebo‐controlled trialClinical & Experimental Allergy, 2006
- The Role of Probiotics in the Management of Allergic DiseaseClinical & Experimental Allergy, 2006
- Toll of allergy reduced by probioticsThe Lancet, 2001